Halozyme Therapeutic (HALO)

While the technology sector has been enjoying ridiculous returns, it’s inevitable that a slowdown (or even a correction) may materialize, which brings to the table…

3 Biotech Stocks to Sell in January Before They Crash and Burn

By Tomas Levani, InvestorPlace Contributor Jan 25, 2024

The biotech industry is one of the most profitable though risky at the same time. Here are three biotech stocks to sell.

7 Underappreciated Biotech Stocks to Pick Up on the Cheap

By Josh Enomoto, InvestorPlace Contributor Nov 9, 2023

Amid some rising questions for the economy, value-seeking investors may want to consider underappreciated biotech stocks. As a sector that, while not immune to broader…

Under the Microscope: 3 Biotech Stocks Pioneering Tomorrow’s Cures

By Muslim Farooque, InvestorPlace Contributor Nov 9, 2023

Unveil the resilience of biotech stocks as they outsmart market trends and champion the race for tomorrow's treatments.

3 Promising Biotech Stocks Flying Under the Radar

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor Nov 8, 2023

Breakthroughs in healthcare are happening everyday, make sure you are keeping up to date on these under the radar biotech stocks.

Millionaire Secrets: 3 Stocks to Turn $1,000 Into a Fortune

By Yiannis Zourmpanos, InvestorPlace Contributor Oct 27, 2023

Are you looking to invest in the stock market and become a millionaire? Here are three stocks to buy to turn $1,000 into a fortune.

7 Sleeper Stocks That Should Be on Every Investor’s Radar This Fall

By Josh Enomoto, InvestorPlace Contributor Sep 23, 2023

Discover the thrill of undervalued and overlooked sleeper stocks poised for growth in a shifting market environment.

7 Meme Stocks to Buy Before They Soar to New Heights in 2023

By Alex Sirois, InvestorPlace Contributor May 25, 2023

Investing in meme stocks is no longer about driving dead and dying companies higher with play money

Why Is Antares Pharma (ATRS) Stock Up Today?

By William White, InvestorPlace Writer Apr 13, 2022

Antares Pharma (ATRS) stock is rocketing higher on Wednesday after the company reached an acquisition agreement with Halozyme (HALO).

7 Best Drug Stocks to Buy for 2022 Without Covid Catalysts

By Thomas Niel, InvestorPlace Contributor Dec 7, 2021

These seven drug stocks, a mix of growth, value, and moonshot plays, each stand to see big moves in the next twelve months.

Why Foot Locker, Inc. (FL), Campbell Soup Company (CPB) and Halozyme Therapeutics, Inc. (HALO) Are 3 of Today’s Worst Stocks

By James Brumley, InvestorPlace Feature Writer May 19, 2017

Foot Locker (FL), Campbell Soup (CPB) and Halozyme Therapeutics (HALO) shareholders won't be starting the weekend in the best of moods.

10 Small-Cap Stocks That Could Double in the Next 3 Months

By James Brumley, InvestorPlace Feature Writer Mar 21, 2017

These small-cap stocks all have the potential to dish out misery, but if things work out just right, look out above.

3 Stocks to Watch on Thursday: Kohl’s Corporation (KSS), Halozyme Therapeutics, Inc. (HALO) and Sears Holdings Corp (SHLD)

By Karl Utermohlen, InvestorPlace Writer Jan 5, 2017

Kohl's (KSS) is battered by an awful holiday performance, Sears (SHLD) sells off Craftsman and Halozyne (HALO) reports strong trial data.

Halozyme Therapeutic (HALO)

3 Breakout Biotech Stocks on Track to Double by 2032

The 3 Best Healthcare Stocks to Buy in June 2024

The 3 Best Biotech Stocks to Buy in May 2024

HALO Stock Earnings: Halozyme Therapeutics Beats EPS, Misses Revenue for Q1 2024

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Halozyme Therapeutic (HALO)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

HALO Stock Predictions, Articles, and Halozyme Therapeutic News

Subscriber Sign in